Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biomarkers of therapeutic response in melanoma and renal cell carcinoma: potential inroads to improved immunotherapy.

× No keyword cloud information.

11 in total

Review 1. Releasing the brake on the immune system: ipilimumab in melanoma and other tumors.

Authors: Ahmad Tarhini; Ernest Lo; David R Minor
Journal: Cancer Biother Radiopharm Date: 2010-12 Impact factor: 3.099

2. Adjuvant Immunotherapy and Radiation in the Management of High-risk Resected Melanoma.

Authors: Ricardo J Gonzalez; Ragini Kudchadkar; Nikhil G Rao; Vernon K Sondak
Journal: Ochsner J Date: 2010

Review 3. Forkhead box proteins: tuning forks for transcriptional harmony.

Authors: Eric W-F Lam; Jan J Brosens; Ana R Gomes; Chuay-Yeng Koo
Journal: Nat Rev Cancer Date: 2013-07 Impact factor: 60.716

Review 4. Melanoma immunotherapy.

Authors: Martina Sanlorenzo; Igor Vujic; Christian Posch; Akshay Dajee; Adam Yen; Sarasa Kim; Michelle Ashworth; Michael D Rosenblum; Alain Algazi; Simona Osella-Abate; Pietro Quaglino; Adil Daud; Susanna Ortiz-Urda
Journal: Cancer Biol Ther Date: 2014-03-20 Impact factor: 4.742

5. Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications.

Authors: Athanassios Kyrgidis; Thrasivoulos-George Tzellos; Stefanos Triaridis
Journal: J Carcinog Date: 2010-04-01

Review 6. Ipilimumab, vemurafenib, dabrafenib, and trametinib: synergistic competitors in the clinical management of BRAF mutant malignant melanoma.

Authors: Jason J Luke; F Stephen Hodi
Journal: Oncologist Date: 2013-05-24

7. Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy.

Authors: Melissa G Lechner; Saman S Karimi; Keegan Barry-Holson; Trevor E Angell; Katherine A Murphy; Connor H Church; John R Ohlfest; Peisheng Hu; Alan L Epstein
Journal: J Immunother Date: 2013 Nov-Dec Impact factor: 4.456

Review 8. Tumor immunosurveillance in human cancers.

Authors: Bernhard Mlecnik; Gabriela Bindea; Franck Pagès; Jérôme Galon
Journal: Cancer Metastasis Rev Date: 2011-03 Impact factor: 9.264

Review 9. The prognostic impact of anti-cancer immune response: a novel classification of cancer patients.

Authors: Gabriela Bindea; Bernhard Mlecnik; Wolf-Herman Fridman; Jérôme Galon
Journal: Semin Immunopathol Date: 2011-04-05 Impact factor: 9.623

10. Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.

Authors: Hideaki Tahara; Marimo Sato; Magdalena Thurin; Ena Wang; Lisa H Butterfield; Mary L Disis; Bernard A Fox; Peter P Lee; Samir N Khleif; Jon M Wigginton; Stefan Ambs; Yasunori Akutsu; Damien Chaussabel; Yuichiro Doki; Oleg Eremin; Wolf Hervé Fridman; Yoshihiko Hirohashi; Kohzoh Imai; James Jacobson; Masahisa Jinushi; Akira Kanamoto; Mohammed Kashani-Sabet; Kazunori Kato; Yutaka Kawakami; John M Kirkwood; Thomas O Kleen; Paul V Lehmann; Lance Liotta; Michael T Lotze; Michele Maio; Anatoli Malyguine; Giuseppe Masucci; Hisahiro Matsubara; Shawmarie Mayrand-Chung; Kiminori Nakamura; Hiroyoshi Nishikawa; A Karolina Palucka; Emanuel F Petricoin; Zoltan Pos; Antoni Ribas; Licia Rivoltini; Noriyuki Sato; Hiroshi Shiku; Craig L Slingluff; Howard Streicher; David F Stroncek; Hiroya Takeuchi; Minoru Toyota; Hisashi Wada; Xifeng Wu; Julia Wulfkuhle; Tomonori Yaguchi; Benjamin Zeskind; Yingdong Zhao; Mai-Britt Zocca; Francesco M Marincola
Journal: J Transl Med Date: 2009-06-17 Impact factor: 5.531